Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...
Phase III of CoreValve’s international trial for its patented 18-French Revalving System is now one-third enrolled since ...
FUJIFLM Medical Systems USA, Inc. (“Fuji”) and Problem Solving Concepts, Inc. (“ProSolv”) have announced a co-marketing ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Agfa HealthCare has signed a contract with the National Heart Centre (NHC) of Singapore, the national referral centre ...
The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...
The American Heart Association has published a report demonstrating that adolescent boys have a significantly increased ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...
Recent downplay of the media’s attention to DES-related thrombosis during both the TCT and AHA conferences this fall may ...
Pulse oximetry, which directly monitors the patient's oxygenation, came into its own as standard medical practice 20 ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
CV Therapeutics has announced it will file a new drug application to the FDA for its regadenoson agent in mid-2007 ...
One of the major dilemmas faced by clinicians in the Intensive Care Unit (ICU) is the determination of volume status and ...
The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Toronto-based Cedara Software, a Merge Healthcare company and an independent developer of medical software technologies ...
Two novel polymer-free drug-eluting stent coating technologies tested in a comparative animal study has concluded with ...
Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators (ICDs), according to a study published in the December 2006 edition of “Heart Rhythm.”